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In 19iO a Chicago physician, Dr. J. B. Herrick,
called attention to a peculiarly formed red cell which
he observed in the blood smear of an anemic West
India .Negro student (Necheles, Allen and Finkel,
1969). Linus Pauling, a physical chemist, demonstrated in 1949 that the protein portion of the hemoglobin molecule found in patients having sickle cell
disease differed from that found in normal adults. Ingram ( 1957) further defined the molecular defect in
that sickled hemoglobin differed from normal adult
hemoglobin in one amino-acid residue per half molecule. The specific molecular identification of the defect
in sickle cell anemia was that of valine replacing the
normally occurring glutamic acid in the number 6 position of the beta chain. This finding provided inspiration
and technical knowledge whereby over 100 different
hemoglobinopathies have now been described. The
clinical explorations which have resulted from studies
of mutant hemoglobin have allowed definition of a
variety of syndromes whose manifestations require
explanation in terms of the effects of molecular distortion on physiqlogical processes. The complex patterns
of inheritance which lead to amino-acid substitution
in either the alpha or beta chain dictate a variety of
structural alterations which may modify hemoglobin
affinity for oxygen, afford protection against falciparum malaria, and provoke changes in microcirculation which influence renal and splenic function.
Whether abnormal hemoglobins induce these changes
is determined at least in part by the site of replacement,
changes on external surfaces exerting little effect, and
the co-existence of abnormalities elsewhere in the
molecule. The discovery of various hemoglobinopathies
has demonstrated that specific molecular defects may
express themselves in various pathophysiological manifestations. For instance, sickle cell anemia, a single
molecular defect of the beta chain in which valine is
substituted for the number 6 amino-acid glutamine,
presents a wide spectrum of clinical manifestations. A
marked dissociation between the degree of anemia and
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the occurrence of other complications may be found.
More detailed pathophysiological studies of patients
with hemoglobinopathies should be performed to gain
a better understanding of the expression of molecular
disease.
Classification of Hemoglobinopathies
A better understanding of the hemoglobinopathies
can be obtained if they are broken down into various
categories. Table I shows these different types of
hemoglobinopathies. The first is a defect in the rate
of synthesis of a specific polypeptide chain. The most
frequently considered clinical disease in this category
is that of thalassemia. In this group of hemoglobinopathies, there is either a defect in the synthesis of
one or more alpha chains or one or more beta chains.
These molecular defects result in specific clinical
syndromes. Beta thalassemia minor may range in
severity from completely asymptomatic elevations of
one of the minor hemoglobin components to a syndrome consisting of splenomegaly, intermittent jaundice, and mild anemia. The peripheral blood in
patients with thalassemia minor shows hypochromia,
microcytosis, anisocytosis, and poikilocytosis. Target
cells ate quite common and the red cells show a
decreased osmotic fragility. Beta thalassemia major
is a more severe disease and is characterized by hypochromic anemia, splenomegaly, and normoblastemia.
These patients are severely affected and have signs of
severe anemia and phenotypically show expanded
facial bones and increased pigmentation. Alpha thalassemia is usually incompatible with life and results
in hydrops fetalis.
The second major categorization of the hemoglobinopathies are those hemoglobins in which a biochemical
alteration in hemoglobin structure has occurred. The
first significant subdivision within this category consists of patients with sickle cell disease, hemoglobin
C, hemoglobin D, and combinations of hemoglobin S
with other hemoglobinopathies such as hemoglobin
SC, SD, and AS.
The next sub-category includes the unstable hemoglobin hemolytic anemias (UHHA). The unstable
hemoglobin hemolytic anemias are characterized by the
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presence of hemolytic anemia -· from infancy. Heinz
bodies are usually seen in the red cells of patients with
this type of anemia. Splenomegaly is usually pr:esent
and when splenectomy is performed the peripheral
blood shows a marked increase in the number of red
cells containing Heinz bodies. Dacie (Dacie et al,
1964) reported studies on five patients with mild
anemia which he characterized as hereditary Heinz
body anemia. A distinctive characteristic of this
group of patients with hemolytic anemia was the presence of Heinz bodies in · a blood suspension stained
with methyl violet. When hemolysates prepared from
washed red cells of all five patients were heated to 50
C for one hour, easily visible precipitates developed. Since •this time, numerous hemoglobinopathies
characterized by hemolytic anemia and thermal lability of the hemolystate have been demonstrated. On
paper or starch gel electrophoresis at an alkaline pH,

the abnormal hemoglobin band is seen as a minor
component moving more slowly than hemoglobin A.
It is extremely difficult to demonstrate these hemoglobinopathies on conventional paper or Agar gel
electrophoresis. Carrell and Lehmann ( 1969) have
reviewed in detail the unstable hemoglobin hemolytic
anemias. It is felt that the globin of the unstable hemoglobins precipitates because it is no longer stabilized
by firm heme to globin bonding. Hemoglobin Zurich
is an example of the unstable hemoglobin hemolytic
anemias in which there is a replacement of the nonheme linked histidine beta 63 by an arginine amioacid. This hemoglobinopathy is characterized by an
increased susceptibility of the individual to hemolysis
as a result of taking sulfonamides. Other examples of
the unstable hemoglobin hemolytic anemias consist of
Ube-I disease. This was described in 1963 in a fifteenyear-old Japanese girl. This has subsequently been

Table I.

HEMOGLOBINOPATHIES
I.

A defect in the rote of synthesis of a specific polypeptide chain
(Alpha and Beta Thalassemia)

II.

A biochemical alteration in hemoglobin structure
A.
Sickle cell disease, Hb. C, D, and combinations of
S with other hemoglobinopathies
B.
The unstable hemoglobin hemolytic anemias (U H H A)
Hb. Sabine, Zurich, Ko ln, Ube-I, Gunhill, and
Freiburg .
C.
Hemoglobins with increased affinity for oxygen
J Capetown, Chesapeake, Yakima, Kempsey, Rainser,
Hiroshi no
D.
Hemoglobins wi th decreased oxygen a ffinity - Hb.
Seattle and Kansas
E.
Hemoglobins unable to combi ne with oxygen - methemoglobin
1) Hb. m disorders - Boston, Saskatoon, luate, Milwaukee
2) Oxidant drugs
3) Diaphorose enzyme de fi c iency DPN dependant system

Ill .

Defect in polypeptide synthesis with stru c tural alterations (sickle/~
Thalassemia disease)
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shown to be similar to hemoglobin Koln which is characterized by blocking of the 93 amino-acid cysteine in
the beta chain.
Schneider (Schneider et al, 1969) described
hemoglobin Sabin disease in which there is a
substitution of the beta chain at the 91 amino-acid
of a lucine amino-acid by a praline residue at
helical position F7 of the beta polypeptide chain.
Other hemoglobinopathies in this group are those of
hemoglobin Sydney (Raik, Hunter and Lindsay, 1967;
Carrell et al, 1967) in which variant a substitution of
valine for alanine at the beta 67 position occurs. Santa
Ana (Opfell, Lorkin and Lehmann, 1968), Gun Hill
(Bradley, Wohl and Rieder, 1967), Torino (Beretta et
al, 1968), Hammersmith (Dacie et al, 1967), Genova
(Sansone, Carrell and Lehmann, 1967), and numerous
other hemoglobinopathies have been described in this
category. On a molecular basis, the instability of hemoglobin molecules is thought to result from either a defect in the heme-binding site, a change in the overall
globin confirmation, or a defect at the site of subunit
interaction where the alpha and beta chains react together (Carrell and Lehmann, 1969). It has been
pointed out that the concentration c f amino-acid substitutions of the unstable hemoglobins in the heme
globin binding site is striking. Of the 11 positions cited
by Perutz ( 1965) as being most closely related to the
heme group, seven are found to be replaced in the unstable hemoglobins. A molecular change which would
alter the stability of the heme globin binding sites
would result in instability of the hemoglobin molecule.
Substitutions of amino-acids lining the heme pocket or
crevice by others that are too large, alter the distribution of electric charges, or permit formation of abnormal cross links within the molecule, decrease its
stability with resultant precipitation of hemoglobin
within the red cell and associated hemolytic anemia.
Another group of changes consists of the substitution
of praline for lucine residues. This changes the overall
globin conformation with loss of stability of the molecule. Another aspect leading to stability of the globin
heme molecule is the site of subunit interaction. It
appears that it is necessary that heme and globin be
bound together for normal solubility and function of
hemoglobin.
The instability of hemoglobin H and Barts which
are tetramers of normal beta and gamma chains respectively, has been previously demonstrated. Substitutions in the area of subunit contact promote dissociation to monomers which are inherently unstable.
The third sub-grouping within this category of alterations in hemoglobin structure consists of those
hemoglobins associated with increased affinity for
oxygen. Charache (Charache, Weatherall and Clegg,
1966) investigated hemoglobin Chesapeake, an alpha
chain variant, which was found to have an increased
oxygen affinity. This hemoglobin is characterized by a
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substitution at the 92 residue of the alpha chain of
lucine for arginine. The amino-acid substitutions in
hemoglobins with increased oxygen affinity have been
found in two areas. One is the area of contact between the alpha 1 and the beta 2 subunits in the
tetramer; the other is near the C-terminal portion
of the beta chain. Hemoglobin Rainier (Stamatoyannopoulos, Yoshida and Adamson, 1968) is the substitution of histidine for invariant residue 23 tyrosine in
the beta hemoglobin polypeptide chain. Hemoglobin
Chesapeake, Yakima, Cape Town, and Kempsey all
have changes in the region between the F and H
helical segments (Jones et al, 1967). These areas
provide the end chain contact between the polar
groups of the alpha and beta chains and are involved in alpha-beta chain interaction. Substitution
in these areas seems to alter the normal respiratory
movements of the subunits such that oxygen .affinity
is increased. It should also be noted that four of these
hemoglobinopathies have remarkably decreased n
values with nearly normal effects.
The fourth sub-grouping within this major category is that of hemoglobins associated with decreased
oxygen affinity characterized by hemoglobin Kansas
(Reissmann, Ruth and Wohours, 1961) in which there
is a substition of asparagine at the 102 residue of
the beta chain by threonine. It is also a result of a
substitution in the area of alpha 1, beta 2 contact.
The heme and globin components of the polypeptide
are linked together by the iron of the heme binding
to a specific histidine residue. This occurs at position
number 87 in the alpha chain and number 92 in the
beta chain. In addition, the histidine residue at number 58 in the alpha chain and number 63 in the beta
chain are bound to the iron of the heme by either
an oxygen molecule in oxyhemoglobin or a water
molecule in desoxyhemoglobin (Necheles, Allen and
Finkel, 1969).
Four of the five hemoglobin M's are produced by
substitutions of the invariant histidine residues on
either side of the iron atom in the heme area (Conley
and Char ache, 1969) . The presence of oxygen tends
to change the iron to the ferric form producing
metbemoglobin, a compound that cannot combine
reversibily with oxygen. The substitution of tyrosine
for histidine renders ferric iron so stable that the
usual intracellular enzymes cannot reduce it to the
functional ferrous (oxygen binding) state.
The maintenance of heme iron in a functional
(Fe ++ )state requires metabolic machinery for reducing iron in ferric form (Fe++ + ) . This is accomplished by a dipyridine nucleotide. DPN (NAD) dependent methemoglobin reductase is a means by which
the diaphorase enzyme acts to convert methemoglobin
(Fe++ + Hb) to functional hemoglobin (Fe++Hb).
Conversion of one or more of the four ferrous atoms
in the hemoglobin molecule to ferric category leads to
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an increased affinity of the remaining ferrous atoms
for oxygen.
Thus, amino acid substitutions and heme-globin
interactions are important in the molecular behavior
of hemoglobin. In addition, cell constituents influence
the oxygen affinity of hemoglobin. Benesch (Benesch
and Benesch, 1967) has shown that the affinity of
hemoglobin may be increased or decreased by its interaction with organic phosphates. Increased intracorpuscular levels of 2-3-Diphosphoglycerate (2,
3-DPG) combine reversibly with deoxyhemoglobin,
shifting the oxygen dissociation curve to the right.
Charache (Charache et al, 1970) has shown that the
concentration of 2-3-DPG is increased in hemoglobin SS erythrocytes as compared to hemoglobin AA
red cells. This may partially explain the decreased oxygen affinity of hemoglobin SS. In addition, increased
levels of 2-3-DPG have been found in low oxygen
tension states and may be an important compensatory
mechanism in hypoxemia.
The third major category of the hemoglobinopathies

are those in which there is a defect in polypeptide
synthesis with a structural alteration combined with
an inability of the individual to synthesize certain of
the alpha or beta polypeptides. An example of this is
sickled-beta thalassemic disease.
Recently we described an example of methemoglobin anemia associated with a Coombs positive
hemolytic anemia. This patient (G.R.) was found to
have increased levels of methemoglobin in his red
cells during a severe hemolytic episode. However, the
majority of his methemoglobin was extracellular consisting of hemoglobin which had been converted to
methemoglobin. The patient showed multisystem degeneration and died in hepatic and renal failure.
Methemoglobin has a characteristic spectral absorption
curve which can be employed in its identification.
Fig 1 shows a spectroscopic analysis of this patient's plasma. The methemoglobin is treated with
cyanide to form cyano-methemoglobin and the change
in light absorption at 632 m/L is measured. This
method is quite specific except for the M hemoglobins

I - Plasma 1: 30 dilution with 0.1 M P04, pH 6.4

2-Plasma + 25,l 596 KCN (pH t )
3- Plasma+ additional 25-l KCN ( pHt)

2

700mµ

660

630 620

600

580

560

Fig I-Spectroscopic analysis of plasma from patient G. R. with hemolytic anemia and free methemoglobin.
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which have anomalous spectroscopic properties. A
simple screening method for this hemoglobin can be
performed by obtaining three tubes of hemolysate or
plasma. One tube is shaken with room air and if it
does not turn red with adequate oxygenation, this
is an indication of an abnormal hemoglobin. Potassium
cyanide should be added to the second tube and if it
turns red this indicates the presence of methemoglobin.
Sulfhemoglobin produces a dark band at 618 mµ.
which is difficult to distinguish from that of methemoglobin in the hand spectroscope. However, it can be
recognized by the fact that it is not removed by the
addition of cyanide. Hydrogen peroxide (3 percent)
causes both of these bands to disappear. Addition of
potassium cyanide and hydrogen peroxide to hemolysates is a simple screening procedure. A more specific
identification can be obtained with a spectroscopic
examination as demonstrated in Fig 1.
Methemoglobin reduction in normal cells may be
accomplished by four known systems. These are
ascorbic acid, glutathione, DPNH diaphorase, and
TPNH diaphorase. Glutathione is maintained in the
reduced state by glutathione reductase, an enzyme
chiefly active with TPNH but also capable of using
DPNH as a substrate. The DPNH diaphorase is by
far the most active reducing methemoglobin.
Another new hemoglobinopathy which has enabled
us to gain insight into both the molecular and
pathophysiology of sickle cell disease is that of hemoglobin Memphis/ S disease. This was initially discovered by Lorraine and Alfred Kraus at the University of
Tennessee (Kraus et al, 1966; Kraus et al, 1967). This
hemoglobinopathy is characterized by a normal and
mutant alpha chain with an alpha .23 glutamine substitution for glutamic acid at residue 23 of the alpha
chain. They have identified two hemoglobin S molecules-one consisting of a// {3.5, and hemoglobin
/ /3." in two subjects.
Memphis/ S consisting of a,M
These patients, homozygous for hemoglobin S and
heterozygous for hemoglobin Memphis, have very mild
sickle cell disease suggesting that the serious consequences of some hemoglobinopathies may be ameliorated by structural changes at other chain positions.
Following the initial investigations by Kraus, we found
a third patient with homozygous hemoglobin S heterozygous for hemoglobin Memphis who exhibited a similar profound dissociation between the degree of his
anemia and the presence of serious complications. Special attention has been directed toward elucidating
the effect of this hemoglobin on blood viscosity in an
effort to account for the benignity of the process
(Cooper et al, 1969).
Our interest in this area was stimulated by (J.P.) a
53-year-old Negro male who has had episodic abdominal and musculoskeletal pain since childhood and
has been repeatedly hospitalized for treatment of
anemia (Fig 2). Despite shortness of breath and
68

Fig 2-Patient J. P., 53-year-old Negro man with hemoglobin Memphis/ S disease.

need for frequent blood transfusions, he worked as a
farm laborer until four years ago when pulmonary
insufficiency forced his retirement. He is 5' 1" tall,
weighs 105 lbs., and his blood pressure ranges from
130- 190 systolic and 85- 100 diastolic. Funduscopic
examination reveals slightly distended retinal veins.
Slit lamp studies have shown no comma-shaped or
curlicue segments of conjunctiva! vessels and no
sludging. He exhibits signs of mild pulmonary emphysema and a Grade IV ejection systolic murmur was
heard at the apex. The liver was smooth and nontender and was felt 5 cm below the right costal
margin. The spleen was nonpalpable. Double distal
interphalangeal palmar creases were present in each
middle finger and on the left fifth finger.
Admission laboratory data shows a urine specific
gravity of 1.010; hemoglobin 9.5 gm/ 100 mg.;
hematocrit 27 vol percent; RBC 3.1 million/ cu ml;
MCV 100 µ. 3 ; MCHC 33 vol percent; reticulocytes 524.6 percent. The creatinine clearance was 59 ml per
minute. The serum folate levels were 19 ng/ 100 ml;
serum iron 149 mcg/ 100 ml and iron binding capacity
244 mcg/ 100 ml. Hemolysis began at 0.34 percent
sodium ch!OFjde and was complete at 0.28 percent in
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an unincubated sample; with incubation, marked resistance to hemolysis was exhibited at lower concentrations of sodium chloride (Fig 3).
Hemoglobin electrophoresis revealed no hemoglobin
A with hemoglobin either in the S or F forms (Fig 4).
Alkali denaturization showed fetal hemoglobin to be
6 percent. Bone marrow aspiration yielded a marrow
which was 100 percent cellular showing marked erythroid hyperplasia and many sickled red blood cells
(Fig 5). Peripheral blood smears contained many
sickled cells and nucleated erythrocytes (Fig 6).
Poikilocytosis was prominent and Howell Jolly bodies
were present. Liver function studies disclosed no evidence of abnormality. An oral cholecystogram demonstrated many small gallstones and a chest film showed
mild left ventricular hypertrophy. Radiographic bone
survey revealed diffuse osteoporotic and osteosclerotic
changes as well as concavity of the vertebral bodies
consistent with sickle cell anemia. No bone infarcts
were seen and at no time could the spleen be visualized
by X-ray. Serum bilirubin was 2.6 mg/ 100 ml of which
2.0 mg/ 100 ml was conjugated. The lactate dehydrogenase was 1980 units and the direct and indirect
Coombs tests were negative.
Routine hematological data were derived by standard techniques. Sickling was ascertained using Sherman's test and minimal concentration gelling of
hemoglobin solution was determined according to the
method of Singer. Numerous isotopic studies consisting of 51Cr labeled erythrocytes, 51Cr labeled platelets,
and heat-treated 51Cr labeled erythrocytes were employed. Hemoglobin electrophoresis was done on starch
gel and cellulose acetate using a discontinuous buffer
at pH 8.6. Individual erythrocytes were stained for
fetal hemoglobin which was then quantitated by alkali
denaturization using Betke's method. After electrophoresis, hemoglobin was characterized by chain separation, tryptic digestion with peptide mapping, a nd
amino acid analysis of aberrant polypeptides according
to Kraus (Kraus, Miyaji and luchi, 1966). Whole blood
viscosity was determined with the falling ball viscometer. Oxygenated a nd deoxygenated blood viscosities were also determined by using a modified
Brookfield viscometer. Renal function studies were
determined and the effect of hyperosmolar solution on
the patient's hemoglobin was also studied.
Fam ily studies were performed and the results
showed a co-dominant inheritance pattern. The Sherman test (Table II) demonstrated 4.5 percent sickled
cells in arterial blood and 21.5 percent in venous
blood. Venous blood from homozygous SS patients
contains 30- 60 percent sickled forms and 5- 20 percent sickled forms in the arterial blood. A minimal
gelling concentration of 27.2 gm/ 100 ml was obtained for S hemoglobin and 35.6 gm/ I 00 ml for
hemoglobin Memphis/ S (Table III). The patient's
deoxygenated blood viscosity was determined by the

UNI NCUBATED OSMOTIC FRAGILITY
HEMOLYSIS BEGINS: 0 .36% NaCl
HEMOLYSIS COMPLETED: 0 . OB% NaCl
NORMAL UNINCUBATED FRAGILITY
HEMOLYSIS BEGINS : 0 .44% NaCl
HEMOLYSIS COMPLETED: 0.28% NaCl
100
90
80
INCUBATED OSMOTIC
FRAGILITY

70
60

30

PROPOSIT~

x

20
10

0.10

0.20 0 .30 0.40 0.50 0.60 0 .70 0.80 0.90
% NaCl

Fig 3-Tncubated osmotic fragility of J. P.'s RBC.

'
•
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j

PATJ,ENT )

Fig 4- H. J . Electrophoresis with cellulose acetate strips
pH 8.6.
69

HEMOGLOBINOPATHIES

Fig 5- Bone marrow aspiration showing hemoglobin
Memphis/ S sickled erythrocyte.

Table II.
MO DIFIED SHERMAN TEST
% SICKLED CELLS (200 CELLS COUNTED)
o:_Acx_A I

fJ SJJ s o:.Ao:.AljJAJJS ct.A o:.M IfJ sfJ s

VENOUS

30 - 60

<1%

21.5

ARTERIAL

5 - 20

0

4. 5

Table III.
THE LO WEST G ELLIN G PO INT CON CENTRATION
O F HEMOGLO BINS CONTAINING HEMO LYSATES
\gm% S)
a Aa A
BOWMAN G RAY

MEMPHI S•

CHI CAGO"

70

I/3 SfJ s

27. 0 gm/ IOO ml
S± .54

19- 24 gm/ 100 ml

aAaM

lfJ SJJ s

(XAa_A / fJAfJS

35.4 gm/ IOO ml
S± 2. 18

26.8 gm/ 100 ml

21.B gm/ 100 ml
S± l.4

13 . 2 gm/ 100 ml
S±l .4

.

Krous - Trans. Ass . Amer. Physicia ns, 1967

u

Singer, K. & Singer, L. Blood, 1953

falling ball method (Fig 7). The result showed that
the viscosity was 3. 7 centipoise units in contrast to
2.77 centipoise units for hemoglobin AA blood and
4.9 centipoise units for hemoglobin SS blood. For
oxygenated blood, comparable values were 3.2, 2.73
and 3.71 centipoise units.
When the Brookfield viscometer was used, no difference in viscosity of oxygenated and deoxygenated
hemoglobin AA blood was found, while patients with
sickle cell trait displayed an increase of 1 ± 0.46 centipoise units in deoxygenated blood. Blood viscosity
increased approximately 27 centipoise units from the
oxygenated to the deoxygenated state at all shear rates
for homozygous SS and SC disease (Fig 8). Although the propositus is homozygous for hemoglobin
SS, his blood viscosity increased by only 1.1 ± 0.1
centipoise units with deoxygenation. The difference in
viscosity between oxygenated and deoxygenated blood
from hemoglobin AA subjects was not significant. For
sickle cell trait, the difference at all shear rates was
> 0.1 and < 0.5 significance level. The difference for
hemoglobin Memphis/ S was > 0.01 and < 0.001. The
difference in viscosity of deoxygenated blood between
hemoglobin Memphis/ S and sickle cell anemia was
signicant at > 0.001 percent level (Fig 9). However, the difference between hemoglobin Memphis/ S
and AS disease blood both with oxygenation and deoxygenation was not significant.
Renal function studies were performed during Mannitol diuresis, sodium loading, and water diuresis (Table IV) . During Mannitol infusion Cosm TcH,o, UV,
and urine flow were decreased in comparison to normal subjects and individuals with hemoglobin SS. With
sodium loading, glomerular filtration and renal plasma
flow were abnormally low and the filtration fraction
was high reflecting a proportionately greater decrease
of the latter. Because of diminished glomerular filtration, filtered sodium was decreased but U N,V was not
suppressed indicating a decreased tubular re-absorption of sodium. Filtered sodium was decreased secondary to suppressed filtration during water loading
but U N, V was greater than in normal hemoglobin SS
subjects. TN• was considerably depressed. Tc"'° was
decreased, indicative of restriction of tubular diluting
activity.
Hemoglobin gelling point of the propositus required
a much higher concentration of hemolysate than that
which was necessary with hemoglobin SS. The quantity of hemoglobin S necessary for gel formation is
decreased by the presence of hemoglobin A and C.
Because our patient demonstrated a high gelling concentration in contradistinction to subjects with sickle
cell anemia or sickle cell trait, the gelling point must
be altered as a result of the structural change in the
hemoglobin molecule resulting from the alpha 23 glutamine substitution.
Changes in blood viscosity revealed by using the
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Brookfield viscometer appear more accurate and
graphic than rheologic activity defined by the falling
ball viscometer (Wells, Denton and Merrill, 1961 ) .
Blood is a non-Newtonian fluid (the relationship between shear stress and shear rate in such a fluid is
non-linear), so the uniform shear rate during
measurement provided by the Brookfield device permits more precise determinations. With the falling
ball, shear rate varies continuously from 0 at the capillary tube and within the fluid not in contact with or
near the ball to some maximal value at the surface
of th e ball or at the wall of the tube. In addition, the
shear rate under these conditions is dependent on the
dimensions of the instruments necessitating correction
for all but the lowest degree of non-Newtonian behavior. Viscosity is also temperature dependent. Our
studies were performed at 37 C.
With the Brookfield instrument we found the viscosity in hemoglobin Memphis/ S disease to be similar
to that found in sickle cell tra it disease but significantly lower than in norm al subjects when the hem atocrit was adjusted to 42-49 vols percent. The difference
fo und in viscosity of oxygenated a nd deoxygenated
blood in these two conditions was significant but the

differences between sickle cell trait and hemoglobin
S/ Memphis were not. Thus, the alpha chain variant
decreases the viscosity of hemoglobin S to the range
found in sickle cell trait.
Sickle cell disease may result in a variety of renal
lesions: impairment in urine concentrating ability,
medullary necrosis, hematuria, and the nephrotic syndrome. Frequent examinations of the urine from our
patient failed to demonstrate erythrocytes, the typical
features of medullary necrosis were not delineated by
intravenous pyelography, and proteinuria was less
than 100 mg/ day. The renal concentrating defect in
sickle cell disease is characterized by a failure of TcH'2o
to increase progressively with hypertonic saline loading with retention of the capacity to attain maximal
levels in response to Mannitol infusion. Our patient
was unable to increase the Tctt 2 o during Mannitol diuresis, probably reflecting chronic rena l disease. This
was additionally manifested by depressed glomerular
filtration and marked diminution in tubular sodium
re-absorption in response to sodium loading and water
diuresis. Diluting capacity response following oral or
parenteral water loading was also impaired, a feature
characteristic of chronic renal disease. While it could
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Fig 6-Peripheral blood from patient J. P. with hemoglobin Memphis/ S disease.
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Renal Function Studies.

Table IV.

TcH 20 DURING 100k MANNITOL DIURESIS

v•
Hb

X

ml/min

UV*
mOsm/min

Cosm*
m!/mih

TcH20*
ml/min

16.7
4.13

6,434
1,130

21.63
3.56

4.9

AA
SD

±

SS
SD

±

16.0
3.04

6,170
1,030

20.2
3. 15

4. 3
0.20

M/SX
SD ±

12.2
0.88

4,300
326

13.7
0.84

1.46
0 . 28

x

0.39

EFFECT OF SODIUM LOADING ON TUBULAR SODIUM TRANSPORT

v
Hb

ml/min

X

AA
SD

±

SS
SD

±

M/S~

SD

±

FNa*
meq/min

UNaV*
meq/min

TNa*
meq/min

4.24

134.4
6.31

17.0
2.60

1. 31
0.40

15.7
1.76

16.5
3.56

170
5.0

22.09
0.93

1.22
0.27

20.87
1.70

12.2
0.98

59.9
4.2

7.9
0.89

1. 33
0.07

6.5
1. l

15.3

x

GFR*
ml/min

RPF*
ml/min

196.6
15.7

EFFECT OF WATER DIURESIS ON TUBULAR SODIUM TRANSPORT

v
Hb

ml/min

x

GFR
ml/min

FNa
meq/min

UNaV
meq/min

TNa
meq/ min

0.38
0.1

16.71
0.41

97.8
0.5

13.4
1. 9

0.41
0.10

21.56
2.1

98. l
0. 11

18. 9
4.1

0.73
0.13

6.75
0.25

88.5
1.8

5.6
1. 2

AA
SD ±

14.8
2.1

123.8
6.1

17.09

SS 5(
SD ±

19.6
3.9

168. 8
17.2

22.0
1.7

M/S~
SD ±

13.03
2.1

59.8
3.9

0.45

7.7
0.40

TNa/FNa*
%

CH20*
ml/min

TABLE IV: Renal function studies of J. F. P. with Hb M/S disease compared to previously reported
studies of patients with Hb. AA and SS Hatch et. al. J.C. I.Vol. 46, No. 3, pp. 336-345, 1967.
•Abbreviations - V= urine flow; UV= solute excretion; COsm= osmolar clearance; TcH20= free water
reabsorption; GFR= glomerular filtration rate; FNa= filtered sodium load; UNaV =urinary sodium
excretion; TNa= tubular sodium reabsorption; RPF= renal plasma flow; TNa/FNa= fraction of t~e
filtered load of sodium reabsorbed; CH20 =free water clearance. Values corrected to 1. 73 M BSA.
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be argued that these changes could result from Memphis hemoglobinopathy or that hemoglobin SS patients
of comparable age might present similar findings, the
weight of clinical evidence seems to favor chronic
renal disease. Renal biopsy failed to reveal the vascular congestion and the accumulation of sickled cells
usually found in glomerular capillaries. Instead, glomerular hypercellularity with endothelial proliferation
and arteriolar nephrosclerosis with arteriolar thickening were found. Thus, it is not possible to assume that
the alpha chain variation modifies the renal concentrating defect of sickle cell disease, although these
studies are suggestive and typical clinical features of
sickle cell disease have not been observed. Younger
and older subjects with hemoglobin Memphis/ S (with
and without hemoglobin S) without chronic renal disease will have to be examined to clarify this point.
The pathological changes of sickle cell disease are
thought to be a result of a formation of sickled cells
under conditions of deoxygenation with increased viscosity, vascular stasis, and occlusion of the microcirculation. Charache and Conley ( 1964) demonstrated that the viscosity of deoxygenated blood varied
directly with the percentage of sickle cells and exponentially with the hematocrit, concluding that the
clinical manifestations of sickle cell anemia could be
attributed to intravascular sickling. To account for
the occasional patient who has a more benign course
even with marked sickling and increased viscosity,
protective extracorpuscular factors were postulated.
Recent studies by Murayama (1964; 1966) and
Perutz (1965; Perutz and Lehmann, 1968) of effects of amino acid substitution on the functional
activity of hemoglobin may afford explanation of these
clinical variations. Murayama proposed that the substitution of a glutamic acid residue at the number 6
position by a valyl residue results in an intramolecular
hydrophobic bond with the N-terminal valine; a cyclic
structure on the beta chain is formed which can lock
into the alpha chain. Muirhead and Perutz (1963)
demonstrated that the beta chains of reduced hemoglobin are 7 Angstrom units further apart than those
of the oxygenated form. Thus, the reduced beta chains
of hemoglobin/ S would fit into the alpha chains which
are not affected by decreased oxygen tension, forming
a rigid tactoid. Murayama postulated that the binding
sites produced by cyclization at the N-terminal part
of the beta chain must fit precisely with the binding
sites on the alpha chain. When the binding sites on
the beta chain move closer together on oxygenation,
the key of the beta chain no longer fits the lock of the
alpha chain. Murayama demonstrated by polarized
light, magnetic orientation, and electron microscopy
that microtubules of hemoglobin/ S were linearly arranged with resulting stacking up of molecules. The
previous patients reported with hemoglobin Memphis/ S
disease have been found to have sickled red cells, but

our patient has been shown to have normal viscosity
with deoxygenation. This molecular defect on the alpha chain must modify the lock so that less rigid tactoids form.
Perutz (Perutz, Kendrew and Watson, 1965) h~s
suggested that the presence of histidine, glutamic acid,
or aspartic acid is necessary for the formation of corners or non-helical regions on globin molecules, and
has found that one of these amino-acids is a constituent
of every corner and occurs in an adjacent area of
every non-helical region. Perutz's model of hemoglo-
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bin describes the 23rd residue of the alpha chain interacting with Number 21 histidine, stabilizing the corner between the alpha and beta helical regions. The loss
of stability at this position with glutamine substitution
for glutamic acid must result in the change in tertiary
conformation. Thus, the instability of the alpha Memphis and beta chain interaction appears to decrease
rigidity of the "lock and key" mechanism-resulting
in normal viscosity, increased gelling concentration and
decreased sickling in the deoxygenated state. Finding
whether or not the alpha chain defect can completely
modify sickle cell disease must await the discovery of
homozygous hemoglobin Memphis/ S disease. The
heterozygous alpha chain defect by itself is not symptomatically expressed.
Additional studies have been performed measuring
the effect of hyperosmolar solutions on the viscosity
of various hemoglobinopathies. Perillie and Epstein
( 1963) reported the effect of hypertonic solutions on
the various hemoglobinopathies. They reported that
sickling occurred within a few seconds in all patients
with sickle cell anemia and sickle cell variants when
their blood was mixed with hypertonic saline. An increase in the sickling in the blood of patients with
sickle cell anemia (SS disease) was first observed in
osmolality of 600 mosm/ kg. As the concentration of
salt solution increased, the percentage of sickle cells
reached a maximum at 600 to 1,000 mosm/ kg. It did
not usually increase with further increase in extracellular tonicity. The same phenomena was observed in
patients with sickle cell trait, but the sickle cells were
less numerous than in subjects with sickle cell anemia.
They proposed that in patients with sickle cell
anemia, sickling may take place in the capillaries of
the renal medulla but that this is partly related to another property of this tissue-its hypertonicity. Thus,
sickling would increase the viscosity of blood entering
the medulla and, therefore, the resistance to blood
flow through the medullary capillaries would be increased. They postulated that by decreasing intermolecular distances within the red cell, intracellular dehydration induced by hypertonicity might be expected
to enhance the additional tendency to sickling produced by hypoxia or acidity. Ham (Ham et al, 1968)
reported on a series of studies investigating
the effect of various solutions on the viscosity
of red cells. His group found that red cells fixed
in glutaraldehyde or formaldehyde were more viscous
than normal cells and the flow properties were more
Newtonian in behavior, thus being less dependent on
shear rate. These authors showed that hyperosmolar
solutions increased the rigidity of the red cells with
an increase in viscosity. They reported that the increase in viscosity, decreased filtration, and resistance
to packing and morphological changes were identical
for oxygenated blood for dogs, normal humans, sickle
cell trait blood, and sickle cell anemia erythrocytes.
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They found no increase in sickling as the osmolar solutions were increased. When red cells from sickle
cell trait and homozygous SS disease were suspended in
600 mosm sodium chloride and then reduced, the viscosity was maximal or became unmeasurable because
the cells behaved like a gel. They postulated that the
hypertonicity of sodium resulted in increased viscosity
of all cells but did not cause sickling of oxygenated
blood. This increase in viscosity could result in decreased flow in the vasa recti with rising concentrations
of the sodium chloride. The decreased rate of flow
would lead to lowered p02 and pH and these in turn
could result in sickling in both homozygous and heterozygous hemoglobin S patients. Hatch (Hatch, Culbertson and Diggs, 1967) stated that although vascular
damage undoubtedly plays an increasingly important
role in sickle cell nephropathy with advancing age, it
does not explain adequately the renal concentrating
defect that is present almost from birth. He proposed
that indirect evidence suggests a possible increase rather than a decrease in medullary blood flow because
of an inability of patients with sickle cell disease during hypertonic saline diuresis to exceed the maximum
clearance of water as obtained during Mannitol diuresis. Thus an increase in medullary blood flow would
produce a loss in renal concentrating ability through a
decrease in medullary solute concentration.
We measured the viscosity of the various hemoglobinopathies at different osmolalities with a Brookfield
viscometer (Table V). The viscosity was measured at
6, 12, 30, and 60 rpm on blood suspended in plasma,
in 300 mosm sodium chloride solution, 600 mosm solution, 800 mosm solution, and 1,000 mosm solution
concentrations (Table VI). Oxygenated cells suspended
in plasma with an hematocrit of 33 vols percent
showed no significant difference between the viscosity
of hemoglobin AA and AS. However, there was a significant increase in the viscosity of hemoglobin AA,
AS, and HS blood at the 0.01 level when compared
to Memphis/ S and SS hemoglobin. Oxygenated blood
at 300 mosm concentration showed a significant increase of hereditary spherocytosis erythrocytes and
hemoglobin SS blood as compared to Memphis/ S and
hemoglobin AS and AA. At 600 mosm, hemoglobin
SS and hereditary spherocytosis blood showed a significant increase at the 0.01 level in viscosity as compared to hemoglobin AA, AS, and Memphis/ S. With
800 mosm solutions, hemoglobin SS and hereditary
spherocytosis (HS) showed a significant increase in
viscosity over hemoglobin Memphis/ S and hemoglobin AA and AS. At 800 mosm solution, Memphis/ S
showed increase in viscosity over hemoglobin AA and
AS at the 0.05 level. At a 1000 mosm solution, hemoglobin AA and AS showed significantly less increase
in viscosity than Memphis/ S, SS, or hereditary spherocytosis. There was no significant difference between
Memphis/ S, SS, and hereditary spherocytic red cells.
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Table V.

OS MOLALITY
PLASMA
HCT 33 Vol.%

OXYGENATED

AS
SS
~
Viscosity in Centipoise Units

AA

DEOXYGENATED

AS
~
!:M1
Viscosity in Centipoise Units

H.S.

RPM

AA

H.S.

6

4.0

4.2

5.2

5.6

4.3

6

4. 1

6. 1

14.1

6.8

3.7

12

3.8

3. 9

5.3

5.0

4. 1

12

3. 8

4. 3

13.0

6.2

3.8

30

3. 7

3.9

5.2

4.7

3.9

30

3. 6

4.0

12 . 2

5.7

3.6

60

3.6

3.8

5. 1

4.6

3.8

60

3.5

3.7

11.7

5.7

3.5

6

2.7

2.7

13.3

4.3

12.5

6

3.0

3.5

20.3

6.0

14.1

12

2.8

2. 5

10.0

4.2

10.3

12

2.9

3.5

13.0

5.8

11. 3

30

2.4

2.4

5.8

3.8

5.7

30

2.7

3.6

8.8

5.6

6.7

60

2.4

2.4

4.3

3.8

4.1

60

2.6

3.7

7. 1

5.7

4.7

6

3.9

5.8

25.7

5.9

24.5

6

2.7

2.8

5.8

8.5

5. 3

12

3.9

4.3

18.3

5.2

'15.5

12

2.8

2.9

6.5

84.

4.7

30

3.0

3. 7

10.5

4.8

8. 2

30

2.7

3.0

7.9

8.5

4. 2

60

2.6

3.0

7.2

4. 4

5. 8

60

2.7

3. 1

8.3

8.6

3.9

300 m OSM

600 m OSM

T able VI.

OS MOLALITY
PLASMA
HCT. 33 Vol. %

OXYGENATED

AS
SS
~
Viscosity in Centipoise Units

DEOXYGENATED

RPM

AA

AA
AS
SS
M/S
Viscosity in Centipoise Units

800 m OSM

6

3.7

5.8

12.4

7.9

23.0

6

4.6

7.6

10.5

11.6

7.4

12

3.7

5.5

9.8

7.2

14.2

12

4.5

5. 3

7.8

11. 1

6.1

30

3.4

4.2

8.5

6.3

7.7

30

4.3

4.3

6.2

10.8

5.0

60

3.3

3.5

7.3

5.9

6.0

60

3.8

3.8

5.5

10.7

4.5

6

3.5

4.2

15.0

10.0

18.4

6

5.5

9.3

6.6

10.1

4.2

12

3.8

4.2

12.5

9.3

10.6

12

5.2

7. l

7.3

9.6

4.3

30

3. 8

4.0

11.0

7.9

6.9

30

5.0

5.5

5.8

9.0

4.3

60

3.8

3.8

7.5

7.0

5.4

60

4.7

4.0

4.8

8.8

4.3

1000 m OSM
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In the oxygenated blood at varying osmolalities from
300 to 1000 mosm solutions, hemoglobin SS and HS
blood behaved in a similar manner. Hemoglobin AA
and AS did not show increasing viscosity with increasing osmolar concentrations, as previously reported by
Hamm and his group. Hemoglobin Memphis/ S did
show an increasing viscosity with increasing osmolalities. Hemoglobin SS and red cells from patients with
hereditary spherocytosis showed a similar pattern
which was of a much greater magnitude than that of
Memphis/ S. The same type of studies were performed
with deoxygenated blood. The hemoglobins listed in
order of ascending viscosity suspended in plasma were
hereditary spherocytic red cells, hemoglobin AA, hemoglobin AS, Memphis/ S, and SS disease. At 300
mosm solution under deoxygenated conditions hemoglobin AA and AS showed significantly less increased
viscosity as compared to Memphis/ S or as compared
to HS or SS blood. At 300 mosm solutions, hemoglobin HS and SS behaved similarly and showed a significantly higher viscosity than the other hemoglobinopathies. Hemoglobin Memphis/ S showed increasing
viscosity with increasing osmolar solutions and at 600,
800, and 1000 mosm concentrations was significantly
higher than any of the other hemoglobinopathies.
Sherman tests were performed on the various hemoglobin solutions at varying osmolar concentrations
and showed that there was no increase in the number
of sickled cells in hemoglobin AS or SS disease at increasing osmolar concentrations, similar to the results
obtainel by Ham and his group at Case Western
Reserve. Hemoglobin Memphis/ S showed an increased
number of sickled cells in hyperosmolar solutions, but
this was a constant number throughout all of the osmolar solutions. The consistent finding was that the
red cells were spherical and crenated with numerous
spicules.
These data suggest that there may be an association
between hereditary spherocytosis and sickle cell disease. A group of investigators from Japan (Matsuda
et al, 1969) reported a case of nephrotic syndrome in
a ten-year-old Japanese boy with hereditary spherocytosis. They pointed out that spherocytosis and sickle
cell anemia have some features in common such as abnormal shape, short erythrocyte survival, persistent
icterus, and occurrence of crises. In addition, there
may be some association between hereditary spherocytosis and sickle cell anemia in reference to a marked
increase in viscosity with hyperosmolar solutions in
oxygenated blood. It has been pointed out by Jensen
( 1969) that the repeated sickling and unsickling of a
cell may cause repetitive fragmentation with proportionally greater membrane than volume Joss which
eventually will result in the production of a spherocyte.
This situation would be most likely to happen during a
sickle cell crisis in which the cells would be subjected
to maximal damage. This may also explain the varying
76
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results reported in patients with hemoglobin SS when
subjected to hyperosmolar solutions.
Some investigators have suggested the use of low
molecular weight dextran in the therapy of patients
with sickle cell anemia. We have measured in an in
vitro situation the effect of various dextran 40 and
dextran 70 concentrations on the viscosity of hemoglobin SS disease (Fig 10, 11, 12). Our findings suggest that dextran actually increases the viscosity of
hemoglobin SS disease. Oski (Oski et al, 1965) reported that low molecular weight dextran was of no
benefit in the therapy of sickle cell crisis.
Eisenberg ( 1969) reported that low molecular
weight dextran had no specific effect on blood viscosity. However, it did prevent erythrocyte rouleau
formation and aggregation. It is also known that the
infusion of low molecular weight dextran is associated
with acute renal failure in at least fourteen patients.
Mailloux (Mailloux et al, 1967) produced acute
anuria in experimental animals with low molecular
weight dextran. They postulated that a reduction in
filtration pressure combined with a marked increase
in urinary viscosity generated by the dextran may lead
to tubular stasis and subsequent tubular blockade.
Laszlo (Laszlo, Obenour and Saltzman, 1969)
studied the effect of hyperbaric oxygenation on erythrocyte sickling during sickle cell crisis. His group at
Durham studied five patients during crises. They
found that the percentage of circulating sickle cells
did decrease during hyperbaric oxygenation. However,
there was no improvement of the sickle cell crisis and
there was no tendency toward improved renal concentrating ability during the hyperbaric oxygenation. A
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